$8.34 Billion is the total value of Matrix Capital Management Company, LP's 19 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NVDA | NVIDIA CORPORATION | $1,376,177,863 | +2.8% | 3,163,700 | 0.0% | 16.51% | +6.2% | |
GLOBALFOUNDRIES INCordinary shares | $992,023,120 | -9.9% | 17,048,000 | 0.0% | 11.90% | -7.0% | ||
AMAT | APPLIED MATLS INC | $976,446,315 | -4.2% | 7,052,700 | 0.0% | 11.71% | -1.1% | |
AMZN | AMAZON COM INC | $932,530,455 | -2.5% | 7,335,828 | 0.0% | 11.19% | +0.7% | |
TDG | TRANSDIGM GROUP INC | $923,143,037 | -5.7% | 1,094,900 | 0.0% | 11.07% | -2.7% | |
MRVL | Buy | MARVELL TECHNOLOGY INC | $712,720,183 | +39.7% | 13,166,824 | +54.3% | 8.55% | +44.2% |
ALTR | Buy | ALTAIR ENGR INC | $706,956,590 | -16.6% | 11,300,457 | +1.1% | 8.48% | -13.9% |
WDAY | WORKDAY INCcl a | $340,761,339 | -4.9% | 1,586,043 | 0.0% | 4.09% | -1.8% | |
SNPS | Buy | SYNOPSYS INC | $329,418,833 | +24.1% | 717,735 | +17.7% | 3.95% | +28.1% |
ASML | ASML HOLDING N V | $292,681,752 | -18.8% | 497,200 | 0.0% | 3.51% | -16.1% | |
ZNTL | ZENTALIS PHARMACEUTICALS INC | $280,037,058 | -28.9% | 13,959,973 | 0.0% | 3.36% | -26.6% | |
QCOM | QUALCOMM INC | $206,682,660 | -6.7% | 1,861,000 | 0.0% | 2.48% | -3.7% | |
ADSK | Buy | AUTODESK INC | $85,660,740 | +251.8% | 414,000 | +247.9% | 1.03% | +263.3% |
ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $63,070,616 | -18.8% | 11,572,590 | 0.0% | 0.76% | -16.1% | |
AURA BIOSCIENCES INC | $48,104,944 | -27.4% | 5,362,870 | 0.0% | 0.58% | -25.1% | ||
PERIMETER SOLUTIONS SA | $33,879,750 | -26.2% | 7,462,500 | 0.0% | 0.41% | -23.8% | ||
ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $30,399,864 | -15.7% | 38,974,185 | 0.0% | 0.36% | -12.9% | |
VENTYX BIOSCIENCES INC | $3,122,227 | +5.9% | 89,900 | 0.0% | 0.04% | +8.8% | ||
ZS | ZSCALER INC | $2,863,634 | +6.3% | 18,405 | 0.0% | 0.03% | +9.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TRANSDIGM GROUP INC | 42 | Q3 2023 | 13.3% |
WORKDAY INC | 42 | Q3 2023 | 19.7% |
NETFLIX INC | 37 | Q2 2022 | 26.1% |
NEW RELIC INC | 29 | Q1 2022 | 7.8% |
DAVITA INC | 26 | Q3 2019 | 6.1% |
ADAPTIMMUNE THERAPEUTICS PLC | 26 | Q3 2023 | 6.8% |
SALESFORCE INC | 23 | Q3 2022 | 18.4% |
CONSTELLATION BRANDS INC | 23 | Q2 2019 | 5.7% |
AMAZON COM INC | 21 | Q3 2023 | 11.2% |
TABLEAU SOFTWARE INC | 20 | Q2 2019 | 15.2% |
View Matrix Capital Management Company, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Adaptimmune Therapeutics PLC | July 10, 2023 | 233,845,110 | 17.3% |
Zentalis Pharmaceuticals, Inc. | June 20, 2023 | 13,959,973 | 19.8% |
ForgeRock, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
NEW RELIC, INC.Sold out | February 13, 2023 | 0 | 0.0% |
Perimeter Solutions, SA | February 13, 2023 | 8,587,500 | 5.4% |
Aura Biosciences, Inc. | December 07, 2022 | 5,362,870 | 14.5% |
Adaptive Biotechnologies Corp | February 14, 2022 | 11,572,590 | 8.2% |
BigCommerce Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
CarGurus, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
Trillium Therapeutics Inc.Sold out | February 14, 2020 | 0 | 0.0% |
View Matrix Capital Management Company, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
SC 13G/A | 2024-02-13 |
13F-HR | 2023-11-14 |
4 | 2023-11-09 |
SC 13D/A | 2023-11-09 |
13F-HR | 2023-08-14 |
SC 13G/A | 2023-07-10 |
4 | 2023-06-20 |
SC 13D/A | 2023-06-20 |
13F-HR | 2023-05-15 |
View Matrix Capital Management Company, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.